No abstract available
Publication types
-
Letter
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Aged
-
Antibodies, Anti-Idiotypic / administration & dosage
-
Antibodies, Anti-Idiotypic / therapeutic use*
-
Antibodies, Monoclonal, Humanized / administration & dosage
-
Antibodies, Monoclonal, Humanized / therapeutic use*
-
Asthma / immunology
-
Asthma / physiopathology
-
Asthma / therapy*
-
Biomarkers / analysis*
-
Child
-
Eosinophilia*
-
Eosinophils
-
Female
-
Humans
-
Hypersensitivity, Immediate / immunology
-
Hypersensitivity, Immediate / physiopathology
-
Hypersensitivity, Immediate / therapy*
-
Male
-
Middle Aged
-
Omalizumab
-
Treatment Outcome
-
United States
-
Young Adult
Substances
-
Antibodies, Anti-Idiotypic
-
Antibodies, Monoclonal, Humanized
-
Biomarkers
-
Omalizumab